Page last updated: 2024-11-04

succinylcholine and Cognition Disorders

succinylcholine has been researched along with Cognition Disorders in 2 studies

Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matthews, JD1
Blais, M1
Park, L1
Welch, C1
Baity, M1
Murakami, J1
Sklarsky, K1
Homberger, C1
Fava, M1
Saxena, RC1
Thacore, VR1
Bhargava, KP1

Other Studies

2 other studies available for succinylcholine and Cognition Disorders

ArticleYear
The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study.
    Journal of psychiatric research, 2008, Volume: 42, Issue:7

    Topics: Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder, Major; Electroconvulsive Therap

2008
Electroconvulsive therapy with intravenous methaqualone.
    The Indian journal of medical research, 1972, Volume: 60, Issue:9

    Topics: Adolescent; Adult; Cognition Disorders; Electroconvulsive Therapy; Female; Humans; Injections, Intra

1972